October 08, 2024 at 1:46 pm

Aditxt (ADTX) and Evofem (EVFM) Continue Strides Toward Improving Women’s Health; Complete Third Parent Equity Investment Under Merger Agreement

Aditxt, Inc. (ADTX), an innovative platform dedicated to accelerating health outcomes and Evofem Biosciences, Inc. (EVFM), women’s health focused company have announced the completion of the Third Parent Equity Investment under the Amended and Restated Merger Agreement. The aim of this investment is to bolster the companies’ strategy and collaboration as they expand access to… [Read More]
October 07, 2024 at 1:51 pm

Scholar Rock (SRRK) Shares Soar over 320% on SMA Topline Results from Phase 3 SAPPHIRE Trial

The late-stage biopharmaceutical company Scholar Rock (SRRK) who focuses on treatments for spinal muscular atrophy (SMA), cardiometabolic disorders, and other serious diseases  has provided topline results from its Phase 3 SAPPHIRE clinical trial that has been evaluating the efficacy and safety of apitegromab, an investigational muscle-targeted therapy, in patients with SMA. The study achieved its… [Read More]
October 07, 2024 at 1:26 pm

Markets Wrap: Stocks Decline as Traders Scale Back Fed Rate Cut Expectations

US 10-Year Yield Tops 4% Amid Bond Selloff; Brent Oil Hits $80 S&P 500 Dips, Amazon Falls on Downgrade; Pfizer Rises on Activist Stake Stocks fell as traders pulled back on bets for Federal Reserve rate cuts, pushing Treasury 10-year yields above 4%. Brent crude surged to $80 a barrel, fueled by concerns over potential… [Read More]
October 04, 2024 at 4:42 pm

Cue Biopharma Shares Surge 40% Ahead of Key Immunotherapy Presentations

 Cue Biopharma (NASDAQ: CUE) shares surged nearly 40% after announcing plans to present data on its Immuno-STAT drug candidates, CUE-101 and CUE-102, at the Society for Immunotherapy of Cancer’s (SITC) 39th Annual Meeting in Houston, Texas, from November 6-10. The company will deliver an oral presentation on the Phase 1 study of CUE-101 for HPV16+… [Read More]
October 04, 2024 at 3:46 pm

IONQ Marks Significant Milestone Advancing Ion-Ion Entanglement

IonQ, (IONQ) a leading player in the quantum computing industry, has reached a major milestone on its path to scaling quantum systems by demonstrating remote ion-ion entanglement. Building on the ion-photon entanglement breakthrough announced in February, this September milestone marks the second of four key steps needed to develop photonic interconnects, a crucial component of… [Read More]